- Report
- September 2025
- 370 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- June 2025
- 400 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- April 2025
- 163 Pages
Europe
From €3044EUR$3,450USD£2,633GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3044EUR$3,450USD£2,633GBP
- Report
- April 2025
- 142 Pages
North America
From €3044EUR$3,450USD£2,633GBP
- Report
- April 2025
- 150 Pages
Africa, Middle East
From €3044EUR$3,450USD£2,633GBP
- Report
- June 2021
- 123 Pages
Global
From €1144EUR$1,297USD£990GBP
- Report
- May 2024
- 343 Pages
Global
From €4235EUR$4,799USD£3,662GBP
- Report
- April 2024
- 270 Pages
Global
From €4412EUR$5,000USD£3,816GBP
- Report
- February 2022
- 272 Pages
Global
From €5294EUR$6,000USD£4,579GBP
- Report
- June 2023
- 317 Pages
Global
From €4368EUR$4,950USD£3,778GBP
- Report
- January 2023
- 356 Pages
Global
From €4368EUR$4,950USD£3,778GBP
- Report
- June 2024
- 103 Pages
Europe
From €1941EUR$2,200USD£1,679GBP
- Report
- January 2022
- 292 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- June 2023
- 361 Pages
Global
From €2427EUR$2,750USD£2,099GBP
€4853EUR$5,500USD£4,197GBP
- Report
- July 2023
- 138 Pages
Global
From €4103EUR$4,650USD£3,549GBP
- Report
- February 2024
- 116 Pages
Europe
From €2603EUR$2,950USD£2,251GBP
- Report
- November 2023
- 183 Pages
United States
From €3485EUR$3,950USD£3,014GBP
- Report
- January 2023
- 217 Pages
Global
From €5250EUR$5,950USD£4,541GBP

Cell and Gene Therapy Manufacturing is a rapidly growing field within the genomics industry. It involves the production of therapeutic cells and genes for use in medical treatments. This includes the production of stem cells, gene-modified cells, and gene-editing tools. The process involves the isolation, expansion, and differentiation of cells, as well as the production of gene-editing tools such as CRISPR-Cas9. The goal is to create therapeutic cells and genes that can be used to treat a variety of diseases.
Cell and Gene Therapy Manufacturing is a highly specialized field, requiring expertise in cell biology, molecular biology, and biochemistry. It also requires the use of advanced technologies such as gene-editing tools, cell culture systems, and bioreactors.
Companies in the Cell and Gene Therapy Manufacturing market include bluebird bio, Cellectis, CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics. These companies are focused on developing and manufacturing therapeutic cells and genes for use in medical treatments. Show Less Read more